AU579501B2 - Peptide immunostimulants - Google Patents

Peptide immunostimulants

Info

Publication number
AU579501B2
AU579501B2 AU65618/86A AU6561886A AU579501B2 AU 579501 B2 AU579501 B2 AU 579501B2 AU 65618/86 A AU65618/86 A AU 65618/86A AU 6561886 A AU6561886 A AU 6561886A AU 579501 B2 AU579501 B2 AU 579501B2
Authority
AU
Australia
Prior art keywords
immunostimulants
peptide
peptide immunostimulants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU65618/86A
Other languages
English (en)
Other versions
AU6561886A (en
Inventor
James Patrick Rizzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/900,934 external-priority patent/US4767743A/en
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of AU6561886A publication Critical patent/AU6561886A/en
Application granted granted Critical
Publication of AU579501B2 publication Critical patent/AU579501B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU65618/86A 1985-11-25 1986-11-24 Peptide immunostimulants Ceased AU579501B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8502351 1985-11-25
WOUS8502351 1985-11-25
US06/900,934 US4767743A (en) 1986-08-27 1986-08-27 Peptide immunostimulants
US900934 1986-08-27

Publications (2)

Publication Number Publication Date
AU6561886A AU6561886A (en) 1987-05-28
AU579501B2 true AU579501B2 (en) 1988-11-24

Family

ID=26772151

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65618/86A Ceased AU579501B2 (en) 1985-11-25 1986-11-24 Peptide immunostimulants

Country Status (12)

Country Link
KR (1) KR900004648B1 (zh)
CN (1) CN1017436B (zh)
AU (1) AU579501B2 (zh)
CA (1) CA1295784C (zh)
DK (1) DK170345B1 (zh)
FI (1) FI86858C (zh)
NO (1) NO170422C (zh)
PH (1) PH22258A (zh)
PL (2) PL150055B1 (zh)
PT (1) PT83796B (zh)
SU (1) SU1560058A3 (zh)
YU (1) YU46183B (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851388A (en) * 1986-01-23 1989-07-25 Pfizer Inc. Heptanoyl-glu-asp-ala-amino acid immunostimulants

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4052385A (en) * 1984-03-30 1985-10-03 Pfizer Inc. Acyltripeptide immunostimulants
AU7746287A (en) * 1986-08-27 1988-03-03 Pfizer Inc. Processes and intermediates for n-(s-3-alkylheptanoyl)-d- gamma-glutamyl-glycyl-d-alanine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4052385A (en) * 1984-03-30 1985-10-03 Pfizer Inc. Acyltripeptide immunostimulants
AU7746287A (en) * 1986-08-27 1988-03-03 Pfizer Inc. Processes and intermediates for n-(s-3-alkylheptanoyl)-d- gamma-glutamyl-glycyl-d-alanine

Also Published As

Publication number Publication date
CN1017436B (zh) 1992-07-15
CA1295784C (en) 1992-02-11
PT83796A (en) 1986-12-01
PL262563A1 (en) 1988-04-28
FI864772A (fi) 1987-05-26
FI864772A0 (fi) 1986-11-24
NO170422B (no) 1992-07-06
YU46183B (sh) 1993-05-28
SU1560058A3 (ru) 1990-04-23
YU200586A (en) 1988-06-30
DK561986D0 (da) 1986-11-24
CN86107931A (zh) 1987-07-01
DK561986A (da) 1987-08-12
AU6561886A (en) 1987-05-28
KR900004648B1 (ko) 1990-07-02
FI86858B (fi) 1992-07-15
FI86858C (fi) 1992-10-26
KR870005012A (ko) 1987-06-04
PL268313A1 (en) 1988-07-07
PH22258A (en) 1988-07-01
NO170422C (no) 1992-10-14
PL150055B1 (en) 1990-04-30
PT83796B (pt) 1989-06-30
PL150129B1 (en) 1990-04-30
NO864689D0 (no) 1986-11-24
DK170345B1 (da) 1995-08-07

Similar Documents

Publication Publication Date Title
AU569821B2 (en) Oxa-azahomocyclostatine polypeptides
ZW1486A1 (en) Peptide derivatives
AU7956487A (en) Peptide derivatives
AU5274386A (en) Peptidylaminodiols
AU5184886A (en) Somatostatines
AU5391286A (en) Trechter
AU569194B2 (en) 5-hydroxy-2-amino-pyrimidines
AU590016B2 (en) Peptides
AU5319886A (en) Immunoregulatory peptides
AU576731B2 (en) Undermattress
AU5224286A (en) Spiro-dioxolanes, - dithiolanes and-oxothiolanes
AU5313686A (en) Verktygsstal
AU5519386A (en) Epicondylitis-bandage
AU5514686A (en) Piperazinecarboxamides
AU5392186A (en) Picfilcylinder
AU6208886A (en) Peptide antibiotics
GB8508685D0 (en) Peptides
AU563024B2 (en) Dihydropyridien
AU6099686A (en) 1-aryl-5-hydrazino-pyrazoles
AU5352786A (en) Nasen-kapseln
AU5452286A (en) Wellenenergieanlage
AU4805485A (en) Schlauchbeutelpackung
AU5352386A (en) Vedenalainen tartuntamenetelma ja-valine
AU579501B2 (en) Peptide immunostimulants
AU5551886A (en) Percussionjig